Lexicon Pharmaceuticals, Inc. (LXRX)
2.325
+0.02
(+1.09%)
USD |
NASDAQ |
Aug 24, 16:00
2.325
0.00 (0.00%)
After-Hours: 20:00
Lexicon Pharmaceuticals Shareholders Equity (Quarterly) : 174.52M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 174.52M |
| March 31, 2026 | 202.86M |
| December 31, 2025 | 107.54M |
| September 30, 2025 | 120.16M |
| June 30, 2025 | 129.44M |
| March 31, 2025 | 123.03M |
| December 31, 2024 | 145.95M |
| September 30, 2024 | 178.51M |
| June 30, 2024 | 239.98M |
| March 31, 2024 | 288.87M |
| December 31, 2023 | 93.11M |
| September 30, 2023 | 139.51M |
| June 30, 2023 | 186.36M |
| March 31, 2023 | 88.05M |
| December 31, 2022 | 117.12M |
| September 30, 2022 | 144.02M |
| June 30, 2022 | 70.83M |
| March 31, 2022 | 92.70M |
| December 31, 2021 | 113.60M |
| September 30, 2021 | 136.60M |
| June 30, 2021 | 137.23M |
| March 31, 2021 | 152.55M |
| December 31, 2020 | 156.37M |
| September 30, 2020 | 87.64M |
| June 30, 2020 | -10.69M |
| Date | Value |
|---|---|
| March 31, 2020 | 54.78M |
| December 31, 2019 | 117.10M |
| September 30, 2019 | 164.71M |
| June 30, 2019 | -64.89M |
| March 31, 2019 | -45.69M |
| December 31, 2018 | -26.40M |
| September 30, 2018 | -29.40M |
| June 30, 2018 | -5.071M |
| March 31, 2018 | 26.19M |
| December 31, 2017 | 52.10M |
| September 30, 2017 | 78.38M |
| June 30, 2017 | 106.31M |
| March 31, 2017 | 134.60M |
| December 31, 2016 | 157.40M |
| September 30, 2016 | 185.18M |
| June 30, 2016 | 217.33M |
| March 31, 2016 | 252.88M |
| December 31, 2015 | 285.85M |
| September 30, 2015 | 197.94M |
| June 30, 2015 | 231.47M |
| March 31, 2015 | 257.61M |
| December 31, 2014 | 284.02M |
| September 30, 2014 | 77.82M |
| June 30, 2014 | 116.67M |
| March 31, 2014 | 140.78M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Viatris, Inc. | 14.26B |
| Pfizer Inc. | 85.19B |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 250.06M |
| Total Liabilities (Quarterly) | 75.54M |
| Debt to Equity Ratio | 0.3394 |
| Current Ratio | 13.37 |
| Net Debt Paydown Yield | 0.88% |